Cibus, Inc. (CBUS)
NASDAQ · Chemicals · Agricultural Chemicals
- Price
- $1.59
- Day
- +1.92%
- Market cap
- $122.04M
Close 2026-09-22.
The company
COMPANY OVERVIEW Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment. Cibus produces these edited plant traits by a unique process that is endeavoring to change the scale and speed of plant breeding for many major agricultural crops. Over the course of its history, Cibus has developed a proprietary time bound and predictable gene editing platform referred to as the Rapid Trait Development System™ ( RTDS ® ).
From Item 1: COMPANY OVERVIEW.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- FMR LLC — $8.49M
- FMR LLC — $7.06M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.15M
- UNITED CAPITAL FINANCIAL ADVISORS, LLC — $789.18K
- GEODE CAPITAL MANAGEMENT, LLC — $599.64K
- Coppell Advisory Solutions LLC — $465.24K
- CERTIOR FINANCIAL GROUP, LLC — $462.66K
- Prescott Group Capital Management, L.L.C. — $449.57K
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Sauer Noel (Sr VP, Research) sold 4 shares at $1.49 on 2025-06-13
- Prante Gerhard (Director) sold 1,150 shares at $1.92 on 2025-02-25
- Prante Gerhard (Director) sold 1,150 shares at $2.07 on 2025-02-24
- Prante Gerhard (Director) sold 1,150 shares at $2.20 on 2025-02-21
- Prante Gerhard (Director) sold 1,150 shares at $2.35 on 2025-02-20
- Prante Gerhard (Director) sold 1,150 shares at $2.58 on 2025-02-19
Recent filings
- 8-K — 2026-08-13
- 10-Q — 2026-08-13
- S-8 — 2026-06-23
- S-8 — 2026-06-23
- 4 — 2026-06-10
- 8-K — 2026-06-09
- 8-K — 2026-06-05
- 4 — 2026-06-04
- 4 — 2026-06-04
- 4 — 2026-06-04